797 related articles for article (PubMed ID: 33731327)
1. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
[TBL] [Abstract][Full Text] [Related]
2. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
[TBL] [Abstract][Full Text] [Related]
3. Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona.
Ulyte A; Radtke T; Abela IA; Haile SR; Ammann P; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
Swiss Med Wkly; 2021 Oct; 151():w30092. PubMed ID: 34797618
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
Ulyte A; Radtke T; Abela IA; Haile SR; Braun J; Jung R; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
Int J Public Health; 2020 Dec; 65(9):1549-1557. PubMed ID: 33063141
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland.
Ulyte A; Haile SR; Blankenberger J; Radtke T; Puhan MA; Kriemler S
Swiss Med Wkly; 2022 Jun; 152():w30193. PubMed ID: 35752960
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland.
Kriemler S; Ulyte A; Ammann P; Peralta GP; Berger C; Puhan MA; Radtke T
Front Pediatr; 2021; 9():645577. PubMed ID: 33796490
[No Abstract] [Full Text] [Related]
9. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Past SARS-CoV-2 Infections: A Prospective Cohort Study Among Swiss Schoolchildren.
Blankenberger J; Haile SR; Puhan MA; Berger C; Radtke T; Kriemler S; Ulyte A
Front Pediatr; 2021; 9():710785. PubMed ID: 34485200
[No Abstract] [Full Text] [Related]
13. Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?
Barcellini L; Forlanini F; Sangiorgio A; Gambacorta G; Alberti L; Meta A; Gaia P; Amendola A; Tanzi E; Massa V; Borghi E; Fabiano V; Zuccotti GV
PLoS One; 2021; 16(9):e0257046. PubMed ID: 34473776
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
[TBL] [Abstract][Full Text] [Related]
15. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
[TBL] [Abstract][Full Text] [Related]
16. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
[TBL] [Abstract][Full Text] [Related]
17. Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain.
García-García E; Rodríguez-Pérez M; Pérez-Solís D; Pérez-Méndez C; Molinos-Norniella C; Cobo-Ruisánchez Á; Fernández Fernández EM; González NG; Calle-Miguel L
World J Pediatr; 2022 Dec; 18(12):835-844. PubMed ID: 36169886
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
20. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A; Koegler F; Dumont R; Dubos R; Zaballa ME; Piumatti G; Coen M; Berner A; Darbellay Farhoumand P; Vetter P; Vuilleumier N; Kaiser L; Courvoisier D; Azman AS; Guessous I; Stringhini S;
Clin Infect Dis; 2022 Mar; 74(4):622-629. PubMed ID: 34043763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
